Design, synthesis and biological evaluation of novel quinazoline-derived EGFR/HER-2 dual-target inhibitors bearing a heterocyclic-containing tail as potential anti-tumor agents
- 31 July 2024
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 151, 107686
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82103998)
- Department of Science and Technology of Liaoning Province (2023JH2/20200171)
This publication has 37 references indexed in Scilit:
- Switching of newly synthesized linker-based derivatives of non-steroidal anti-inflammatory drugs toward anti-inflammatory and anticancer activityBioorganic Chemistry, 2023
- Novel third-generation pyrimidines-based EGFR tyrosine kinase inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancerBioorganic Chemistry, 2022
- Discovery of N-(1,3,4-thiadiazol-2-yl)benzamide derivatives containing a 6,7-methoxyquinoline structure as novel EGFR/HER-2 dual-target inhibitors against cancer growth and angiogenesisBioorganic Chemistry, 2022
- Revisiting ageless antiques; synthesis, biological evaluation, docking simulation and mechanistic insights of 1,4-Dihydropyridines as anticancer agentsBioorganic Chemistry, 2021
- EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitorBioorganic Chemistry, 2019
- Synthesis of aryl pyrazole via Suzuki coupling reaction, in vitro mushroom tyrosinase enzyme inhibition assay and in silico comparative molecular docking analysis with Kojic acidBioorganic Chemistry, 2018
- Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligandsBioorganic Chemistry, 2018
- Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatmentCancer Letters, 2016
- Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitorsBioorganic & Medicinal Chemistry, 2013
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010